SEC Form 4 · accession 0001144204-15-020893
Synthetic Biologics, Inc. · SYN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Alan Wolf
Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 2, 2015 · 3:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2015 | M | 10,842 | $0.09 | A | 10,842 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $0.09 | Apr 1, 2015 | M | 10,842 | D | Jun 1, 2005 | Jun 1, 2015 | Common Stock | 10,842 | 0 | D |
Explanation of responses
- F1The exercise price and number of shares have been adjusted to take into account a 1-for-3 reverse stock split that was effected on April 24, 2007.